Paul L Bellamy

FDA Investigator Report

Total Inspections: 225

Total 483s Issued: 32

Total Warning Letters Issued: 5

Inspection Details

Longest Inspection: 33 days

Shortest Inspection: 1 days

Average Length of Inspection: 3.2 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Recent Inspections

DateCompanyCityCountryFEI Number483
2017-08-11Novitium Pharma LLCEast WindsorUnited States3012541241
2017-06-28SOFIE CoTotowaUnited States3008415560
2017-06-13Fersinsa Gb SA de CVRamos ArizpeMexico3000538793
2017-05-23Akorn Inc.CranburyUnited States3013036275
2017-05-12Akorn Inc.SomersetUnited States2246848
2017-04-26Renaissance Lakewood, LLCLakewoodUnited States2242829
2017-04-04Hikma Pharmaceuticals USA Inc.Cherry HillUnited States2220525
2017-03-20Amneal Pharmaceuticals, LLCPiscatawayUnited States3008861605
2017-02-23EMSL Analytical, Inc.CinnaminsonUnited States3003933331
2017-02-14Novel Laboratories, Inc. d.b.a Lupin SomersetSomersetUnited States3006271438

Sign Up to get the complete report.

Download 483s and EIRs for Paul L Bellamy

Co-Inspectors

NameInspectionsLast Inspection
Nancy M Espinal62017
Maria Estrella32016
Lauren L Vajo32014
Atul Agrawal32011
Justine Tomasso32011
Nicholas A Violand32010
Devon Jenkins32009
Addam S Reynolds22010
Luis A Carrion12017
Thomas E Friel12015
Adetutu M Gidado12015
Stephen J Mottola12014
Nikki S Ramirez12013
Patricia A Mcilroy12013
Frederick Razzaghi12013
Patsy J Domingo12011
Paula J Bretz12011
Matthew R Noonan12011
Patric C Klotzbuecher12011
Jose M Cayuela12011
Helen Verdel12010
Cara M Minelli12010
Krystyna M Kitson12009
Meredith L Sheridan12009

Active Locations

Year-wise Inspection Count